GoAI
Get started
Transcat, Inc. logo

Transcat, Inc.

TRNS

NASDAQIndustrialsSpecialty Business Services

Open in GoAI

Previous close

$92.50

+$0.99 · +1.08%

Aug 21, 4:00 PM ET

Pre-market

$92.71

+$0.21 · +0.23%

Aug 24, 7:29 AM ET

TRNS company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Hold

Wait — insufficient conviction to act

Valuation

16

Overpriced

Momentum

66

Gaining

Sentiment

57

Mixed

Risk resilience

66

Moderate Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

Transcat, Inc. is a provider of accredited calibration and laboratory instrument services, and a value-added distributor of professional grade test, measurement, and control instrumentation. The company operates through two segments, Service and Distribution, and focuses on providing services and products to highly regulated industries, particularly the life science industry, which includes pharmaceutical, biotechnology, and medical device businesses.

Industry
Specialty Business Services
Sector
Industrials
Headquarters
US
CEO
Jaime A. Irick
Listed since
Dec 5, 1977
Employees
1,413

Market position

Day range

Current $92.50

52-week range

Current $92.50

Open
$92.205
Previous close
$91.51
Volume
72.51K
0.46× average
Average volume
156.45K
Average daily volume
Market cap
865.78M USD
Beta
0.67
Market reference 1
50-day average
$90.2686
+2.47% above average
200-day average
$74.6595
+23.90% above average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
789.64M USD
P/E (TTM)
250×
P/B (TTM)
2.86×
P/S (TTM)
2.49×
EV / EBITDA
20.37×
Earnings yield
0.81%
Free cash flow yield
2.94%
Dividend yield
0.00%

Profitability & efficiency

Gross margin
32.50%
Operating margin
3.02%
Net margin
0.99%
Return on equity
1.79%
Return on assets
1.12%
Return on invested capital
2.02%

Financial health

Debt / equity
0.47×
Current ratio
2.33×
Altman Z-score
3.94
Piotroski F-score
4 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends36%23%11%-1%Gross margin, FY2022: 28.51%Gross margin, FY2023: 29.65%Gross margin, FY2024: 32.30%Gross margin, FY2025: 32.13%Gross margin, FY2026: 32.63%Operating margin, FY2022: 6.90%Operating margin, FY2023: 7.05%Operating margin, FY2024: 7.62%Operating margin, FY2025: 6.42%Operating margin, FY2026: 4.00%Net margin, FY2022: 5.55%Net margin, FY2023: 4.64%Net margin, FY2024: 5.26%Net margin, FY2025: 5.21%Net margin, FY2026: 1.62%FY2022FY2023FY2024FY2025FY2026
Gross margin FY2022 28.51%. Gross margin FY2023 29.65%. Gross margin FY2024 32.30%. Gross margin FY2025 32.13%. Gross margin FY2026 32.63%. Operating margin FY2022 6.90%. Operating margin FY2023 7.05%. Operating margin FY2024 7.62%. Operating margin FY2025 6.42%. Operating margin FY2026 4.00%. Net margin FY2022 5.55%. Net margin FY2023 4.64%. Net margin FY2024 5.26%. Net margin FY2025 5.21%. Net margin FY2026 1.62%.

Income trends

Revenue

331.88M USD+19.20%

Operating income

13.26M USD-25.80%

Net income

5.38M USD-62.96%
Income trends across reported periods364.53M USD233.93M USD103.33M USD−27.27M USDRevenue, FY2022: 204.96M USDRevenue, FY2023: 230.57M USDRevenue, FY2024: 259.48M USDRevenue, FY2025: 278.42M USDRevenue, FY2026: 331.88M USDOperating income, FY2022: 14.14M USDOperating income, FY2023: 16.25M USDOperating income, FY2024: 19.78M USDOperating income, FY2025: 17.87M USDOperating income, FY2026: 13.26M USDNet income, FY2022: 11.38M USDNet income, FY2023: 10.69M USDNet income, FY2024: 13.65M USDNet income, FY2025: 14.52M USDNet income, FY2026: 5.38M USDFY2022FY2023FY2024FY2025FY2026
Revenue FY2022 204.96M USD. Revenue FY2023 230.57M USD. Revenue FY2024 259.48M USD. Revenue FY2025 278.42M USD. Revenue FY2026 331.88M USD. Operating income FY2022 14.14M USD. Operating income FY2023 16.25M USD. Operating income FY2024 19.78M USD. Operating income FY2025 17.87M USD. Operating income FY2026 13.26M USD. Net income FY2022 11.38M USD. Net income FY2023 10.69M USD. Net income FY2024 13.65M USD. Net income FY2025 14.52M USD. Net income FY2026 5.38M USD.
Metric (USD)FY2026FY2025FY2024FY2023FY2022
Revenue331.88M USD278.42M USD259.48M USD230.57M USD204.96M USD
Cost of goods sold223.57M USD188.97M USD175.68M USD162.21M USD146.52M USD
Gross profit108.3M USD89.45M USD83.81M USD68.36M USD58.44M USD
Selling, general, and administrative95.04M USD71.58M USD64.03M USD52.11M USD44.3M USD
Operating expenses95.04M USD71.58M USD64.03M USD52.11M USD44.3M USD
Interest income—825K USD808K USD——
Interest expense5.27M USD798K USD1.84M USD2.42M USD810K USD
Depreciation and amortization26.17M USD18.57M USD13.54M USD10.96M USD9.57M USD
Operating income13.26M USD17.87M USD19.78M USD16.25M USD14.14M USD
Net income5.38M USD14.52M USD13.65M USD10.69M USD11.38M USD

Company facts updated Aug 24, 2026.

Earnings

EPS beat rate
55%
6 beats, 5 misses, 0 met estimates
Average EPS surprise
-0.61%
11 comparable reports
Latest EPS result
0.14
Estimate 0.38 · Miss by 62.91%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly EPS actual values compared with estimates0.70.510.310.12Q1 '25BeatQ2 '25MissQ3 '25BeatQ4 '25MissQ1 '26MissQ2 '26BeatQ3 '26MissQ4 '26Estimate
Q1 2025, reported Jan 27, 2025: actual 0.45, estimate 0.38, surprise +18.42%, Beat. Q2 2025, reported May 19, 2025: actual 0.64, estimate 0.66, surprise -3.03%, Miss. Q3 2025, reported Aug 6, 2025: actual 0.59, estimate 0.4, surprise +47.50%, Beat. Q4 2025, reported Nov 3, 2025: actual 0.14, estimate 0.418, surprise -66.47%, Miss. Q1 2026, reported Feb 3, 2026: actual 0.26, estimate 0.3, surprise -13.33%, Miss. Q2 2026, reported May 26, 2026: actual 0.56, estimate 0.51, surprise +9.80%, Beat. Q3 2026, reported Aug 4, 2026: actual 0.14, estimate 0.378, surprise -62.91%, Miss. Q4 2026, reported Nov 2, 2026: actual —, estimate 0.41, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates96.66M85.45M74.25M63.04MQ1 '25MissQ2 '25BeatQ3 '25BeatQ4 '25MissQ1 '26BeatQ2 '26MissQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Jan 27, 2025: actual 66.75M USD, estimate 70.29M USD, surprise -5.04%, Miss. Q2 2025, reported May 19, 2025: actual 77.13M USD, estimate 76.67M USD, surprise +0.61%, Beat. Q3 2025, reported Aug 6, 2025: actual 76.42M USD, estimate 72.28M USD, surprise +5.73%, Beat. Q4 2025, reported Nov 3, 2025: actual 82.27M USD, estimate 89.84M USD, surprise -8.42%, Miss. Q1 2026, reported Feb 3, 2026: actual 83.86M USD, estimate 80.59M USD, surprise +4.05%, Beat. Q2 2026, reported May 26, 2026: actual 89.33M USD, estimate 89.79M USD, surprise -0.51%, Miss. Q3 2026, reported Aug 4, 2026: actual 92.95M USD, estimate 86.55M USD, surprise +7.39%, Beat. Q4 2026, reported Nov 2, 2026: actual —, estimate 92.42M USD, surprise —, Comparison unavailable.

Analyst ratings

Third-party consensus; not a GoAI recommendation.

Analyst price target

Average target

$123.6

33.62% upside
Past 12 months12-month forecastHigh $160Average $123.6Low $94.00

Rating distribution

10 ratings
Strong buy00%
Buy880%
Hold220%
Sell00%
Strong sell00%

Recent analyst actions

4 institutions

TRNS news

defenseworld.net

Dimensional Fund Advisors LP Grows Position in Transcat, Inc. $TRNS

Dimensional Fund Advisors LP grew its position in Transcat, Inc. (NASDAQ: TRNS) by 3.7% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The…

Read source
seekingalpha.com

Transcat, Inc. (TRNS) Q1 2027 Earnings Call Transcript

Transcat, Inc. (TRNS) Q1 2027 Earnings Call Transcript

Read source
marketbeat.com

Transcat Q1 Earnings Call Highlights

Transcat NASDAQ: TRNS reported first-quarter fiscal 2027 revenue of $92.9 million, up 22% from a year earlier, as both its calibration services and distribution segments posted double-digit growth. The company said…

Read source
zacks.com

Transcat, Inc. (TRNS) Q1 Earnings and Revenues Top Estimates

Transcat, Inc. (TRNS) came out with quarterly earnings of $0.51 per share, beating the Zacks Consensus Estimate of $0.37 per share. This compares to earnings of $0.59 per share a year ago.

Read source
businesswire.com

Transcat Reports Strong Fiscal First Quarter 2027 Financial Results with Double-Digit Service Organic Revenue* Growth and Service Gross Margin Expansion

ROCHESTER, N.Y.--(BUSINESS WIRE)--Transcat Reports Strong Fiscal First Quarter 2027 Results with Double-Digit Service Organic Revenue Growth and Service Gross Margin Expansion.

Read source
businesswire.com

Transcat to Host First Quarter Fiscal Year 2027 Conference Call and Webcast on Tuesday, August 4, 2026 at 4:30 p.m. Eastern Time

ROCHESTER, N.Y.--(BUSINESS WIRE)--Transcat to Host First Quarter Fiscal Year 2027 Conference Call and Webcast on Tuesday, August 4, 2026 at 4:30 p.m. Eastern Time.

Read source

Corporate actions

Corporate action history

Stock split

Effective Jul 23, 1997

2:1

Stock split

Effective Aug 3, 1982

2:1

Stock split

Effective Aug 4, 1981

2:1

TRNS peers

Space Exploration Technologies Corp. logo

SPCX

Space Exploration Technologies Corp.

$136.97

+2.22%

CSX Corporation logo

CSX

CSX Corporation

$51.59

+1.22%

Cintas Corporation logo

CTAS

Cintas Corporation

$203.79

+0.13%

PACCAR Inc logo

PCAR

PACCAR Inc

$131.03

+1.62%

Honeywell International Inc. logo

HON

Honeywell International Inc.

$215.9

-1.11%

Fastenal Company logo

FAST

Fastenal Company

$51.26

+1.18%

ETFs holding TRNS

Funds reporting this stock among their holdings, ordered by reported position size.

Vanguard Morningstar Total Stock Market ETF logoVanguard Morningstar Total Stock Market ETFVTI
Market value
25.46M
Weight
0.00%
AUM
2.3T USD
Expense ratio
0.03%
Price / 1D
$378.24+0.44%
iShares Russell 2000 ETF logoiShares Russell 2000 ETFIWM
Market value
21.87M
Weight
0.03%
AUM
81.62B USD
Expense ratio
0.19%
Price / 1D
$299.96+0.77%
Thrivent Small-Mid Cap Equity ETF logoThrivent Small-Mid Cap Equity ETFTSME
Market value
11.73M
Weight
1.21%
AUM
968.94M USD
Expense ratio
0.65%
Price / 1D
$48.61+0.81%
Vanguard Extended Market ETF logoVanguard Extended Market ETFVXF
Market value
9.22M
Weight
0.01%
AUM
93.7B USD
Expense ratio
0.05%
Price / 1D
$245.53+0.82%
iShares Russell 2000 Growth ETF logoiShares Russell 2000 Growth ETFIWO
Market value
4.49M
Weight
0.03%
AUM
15.16B USD
Expense ratio
0.24%
Price / 1D
$387.37+1.24%
Vanguard Russell 2000 ETF logoVanguard Russell 2000 ETFVTWO
Market value
4.49M
Weight
0.03%
AUM
17.4B USD
Expense ratio
0.06%
Price / 1D
$121.25+0.74%
Schwab U.S. Small-Cap ETF logoSchwab U.S. Small-Cap ETFSCHA
Market value
4.09M
Weight
0.02%
AUM
23.1B USD
Expense ratio
0.03%
Price / 1D
$34.83+0.52%
iShares Russell 2000 Value ETF logoiShares Russell 2000 Value ETFIWN
Market value
3.46M
Weight
0.02%
AUM
14.66B USD
Expense ratio
0.24%
Price / 1D
$224.81+0.45%

Continue in GoAI

Research TRNS

research.disclaimer